Curanex Pharmaceuticals CURX
NASDAQ CURX
$4.92 -0.06 (-1.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Curanex Pharmaceuticals (CURX) Consolidated Net Income (2024 - 2026)

Updated

Curanex Pharmaceuticals (CURX) posted Consolidated Net Income of -$3.33 million for Q2 2026, compared with -$60,749 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Consolidated Net Income (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Curanex Pharmaceuticals was -$7.43 million; for FY2025, it was -$4.25 million.

  • In prior years, Curanex Pharmaceuticals' Consolidated Net Income was -$365,062 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Curanex Pharmaceuticals 6.98 Mn -6.87 Mn - -3.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.33 Mn
Dec 31, 2025 -3.09 Mn
Sep 30, 2025 -955,417.00
Jun 30, 2025 -60,749.00
Dec 31, 2024 -147,366.00
Sep 30, 2024 -93,295.00
API Access

Curanex Pharmaceuticals Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=CURX&period=max&api_key=YOUR_API_KEY